Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 4;10(1):59.
doi: 10.1038/s41421-024-00676-x.

Leptin receptor neurons in the ventral premammillary nucleus modulate emotion-induced insomnia

Xiang-Shan Yuan #  1 , Zhe Xiang #  2 , Jian-Bo Jiang #  2 , Fang Yuan #  3 , Mu-Tian Zhang  2 , Kai-Ying Zhang  2 , Zhao-Yi Chen  2 , Wei-Min Qu  2 , Wen-Sheng Li  4 , Zhi-Li Huang  5
Affiliations

Leptin receptor neurons in the ventral premammillary nucleus modulate emotion-induced insomnia

Xiang-Shan Yuan et al. Cell Discov. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Inhibition of PMvLepR neurons rescues emotion-induced insomnia-like behavior.
a Schematic showing experimental protocol for EEG/EMG recording and emotional stimuli. b The latency of NREM sleep onset following male mouse urine (blue), female mouse urine (red), male rat urine (green), TMT (magenta) and saline (black) (n = 6, one-way ANOVA). To maintain consistency, identical color coding for each group is applied throughout all subsequent figure panels. c Total amount of wakefulness (left), NREM sleep (right) during 2 h (10:00–12:00) following various stimuli (n = 6, paired t-test). d Representative images showing co-localization (arrowheads) of c-Fos with LepR signals in the PMv following various stimuli. Scale bars, 50 µm. e Quantification of the number of c-Fos+ cells in the PMv for each treatment (left, n = 4, one-way AVONA) and the percentage of c-Fos+/LepR+ cells in the c-Fos+ population in the PMv for each treatment (right). f Schematic of fiber-photometry recordings and an image showing GCaMP6f (green) expression in PMvLepR neurons of LepR-Cre mouse. Scale bar, 200 µm. g Heatmap (upper) of average ΔF/F signal when animals sniffing different stimuli and saline, and average calcium transients (lower) when animals sniffing different stimuli and saline (n = 6, values of average ΔF/F signal were averages of 3 trials for each animal). h Quantification of stimuli-induced peak ΔF/F (%) for exposed animals (n = 6, one-way AVONA). i Schematic of viral strategy to chemogenetically activate PMvLepR neurons. j Representative image showing that CNO induced c-Fos/hM3Dq-expressing neurons of the PMv. Scale bar, 100 μm. k, l Examples of relative EEG power, time course changes in wakefulness, amount of wakefulness during the 5 h following vehicle or CNO injections at light (k) and dark period (l) (n = 6, two-way repeated measures ANOVA, paired t-test). m Schematic of virus strategy in the PMv of LepR-Cre mice, with mCherry or hM4Di virus and the experimental timeline for stimuli or CNO treatment. n, p, r, t The latency of NREM sleep following vehicle or CNO in PMvLepR-hM4Di mice, and Δ Latency to NREM sleep of PMvLepR-mCherry and PMvLepR-hM4Di mice after male mouse urine exposure (n), female mouse urine exposure (p), male rat urine exposure (r), TMT exposure (t) or saline exposure (n = 6, ANOVA for factorial design). o, q, s, u Total amount of wakefulness and NREM sleep during 2 h (10:00–12:00) following vehicle or CNO in PMvLepR-hM4Di after male mouse urine exposure (o), female mouse urine exposure (q), male rat urine exposure (s), TMT exposure (u), or saline exposure (n = 6, paired t-test). Data represent mean ± sem, *P < 0.05, **P < 0.01.
See this image and copyright information in PMC

References

    1. Hall M, et al. Medicine. 2004;66:56–62. - PubMed
    1. Cano G, Mochizuki T, Saper CB. J. Neurosci. 2008;28:10167–10184. doi: 10.1523/JNEUROSCI.1809-08.2008. - DOI - PMC - PubMed
    1. Winsky-Sommerer R, et al. J. Neurosci. 2004;24:11439–11448. doi: 10.1523/JNEUROSCI.3459-04.2004. - DOI - PMC - PubMed
    1. Chen AX, et al. Neuron. 2020;108:763–774. doi: 10.1016/j.neuron.2020.08.025. - DOI - PubMed
    1. Li SB, et al. Sci. Adv. 2020;6:eabc2590. doi: 10.1126/sciadv.abc2590. - DOI - PMC - PubMed